PL353321A1 - Hydrodynamically balancing oral drug delivery system - Google Patents

Hydrodynamically balancing oral drug delivery system

Info

Publication number
PL353321A1
PL353321A1 PL00353321A PL35332100A PL353321A1 PL 353321 A1 PL353321 A1 PL 353321A1 PL 00353321 A PL00353321 A PL 00353321A PL 35332100 A PL35332100 A PL 35332100A PL 353321 A1 PL353321 A1 PL 353321A1
Authority
PL
Poland
Prior art keywords
hydrodynamically
delivery system
drug delivery
oral drug
balancing
Prior art date
Application number
PL00353321A
Other languages
Polish (pl)
Inventor
Naresh Talwar
John N. Staniforth
Michael J. Tobyn
Original Assignee
Ranbaxy Laboratories Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Limited filed Critical Ranbaxy Laboratories Limited
Publication of PL353321A1 publication Critical patent/PL353321A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL00353321A 1999-08-04 2000-08-01 Hydrodynamically balancing oral drug delivery system PL353321A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/IB1999/001386 WO2001010405A1 (en) 1999-08-04 1999-08-04 Hydrodynamically balanced oral drug delivery system
PCT/IB2000/001083 WO2001010419A1 (en) 1999-08-04 2000-08-01 Hydrodynamically balancing oral drug delivery system

Publications (1)

Publication Number Publication Date
PL353321A1 true PL353321A1 (en) 2003-11-17

Family

ID=11004886

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00353321A PL353321A1 (en) 1999-08-04 2000-08-01 Hydrodynamically balancing oral drug delivery system

Country Status (21)

Country Link
EP (1) EP1206249A4 (en)
JP (1) JP2003506400A (en)
CN (1) CN1376059A (en)
AP (1) AP2002002410A0 (en)
AU (2) AU5060499A (en)
BR (1) BR0012981A (en)
CA (1) CA2378468A1 (en)
CZ (1) CZ2002415A3 (en)
EA (1) EA200200126A1 (en)
HK (1) HK1047226A1 (en)
HR (1) HRP20020108A2 (en)
HU (1) HUP0202497A3 (en)
IL (1) IL147966A0 (en)
MX (1) MXPA02001272A (en)
NZ (1) NZ516959A (en)
OA (1) OA12003A (en)
PL (1) PL353321A1 (en)
SK (1) SK1832002A3 (en)
TR (1) TR200200467T2 (en)
WO (2) WO2001010405A1 (en)
ZA (1) ZA200200926B (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100457458B1 (en) * 2001-04-02 2004-11-17 삼아약품 주식회사 Rapidly dissolving tablet and process for preparing same
KR20040018394A (en) 2001-07-04 2004-03-03 썬 파마슈티컬 인더스트리스 리미티드 Gastric retention controlled drug delivery system
WO2003037296A2 (en) * 2001-10-29 2003-05-08 Labopharm Inc. Methods and dosage forms for improving the bioavailability of therapeutic agents
US20050226926A1 (en) 2002-07-25 2005-10-13 Pfizer Inc Sustained-release tablet composition of pramipexole
WO2005020879A2 (en) * 2003-08-27 2005-03-10 Vecta Ltd. Compositions for treating pathologies that necessitate suppression of gastric acid secretion
TW200533391A (en) * 2004-03-25 2005-10-16 Sun Pharmaceutical Ind Ltd Gastric retention drug delivery system
CN101005830B (en) 2004-08-13 2010-09-29 贝林格尔·英格海姆国际有限公司 Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
DE102004042139B4 (en) * 2004-08-31 2009-06-10 Aristocon Verwaltungs- Gmbh Peroral dosage forms to achieve a retarding effect after drug intake with a meal
EP1690540A1 (en) * 2005-02-15 2006-08-16 Neuro3D Composition comprising ocaperidone
AU2006330526B2 (en) 2005-12-22 2012-09-27 Oakwood Laboratories, Llc Sublimable sustained release delivery system and method of making same
EP1886665A1 (en) * 2006-08-01 2008-02-13 Boehringer Ingelheim Pharma GmbH & Co. KG Gastro retentive delivery system
US10888521B2 (en) * 2007-03-02 2021-01-12 Farnam Companies, Inc. Sustained release compositions using wax-like materials
BRPI0917444A2 (en) 2008-08-15 2015-12-01 Depomed Inc gastric retention pharmaceutical compositions for the treatment and prevention of snc diseases
EP2329810A4 (en) 2008-08-18 2012-09-19 Team Academy Of Pharmaceutical Science Gastric retention drug delivery system, preparation method and use thereof
JP2012505203A (en) 2008-10-08 2012-03-01 バイオプラス ライフ サイエンスズ ピーヴイティ リミテッド Sustained release drug delivery system
EP2283824B1 (en) 2009-07-30 2017-04-19 Special Products Line S.p.A. Compositions and formulations based on swellable matrices for sustained release of poorly soluble drugs such as clarithromycin
JP2013103879A (en) * 2011-11-10 2013-05-30 Nakanihon Capsule Co Ltd Hard capsule
KR102241487B1 (en) 2013-02-20 2021-04-16 주식회사 종근당 Pharmaceutical composition consisting of sustained-release pellets
WO2014144661A1 (en) * 2013-03-15 2014-09-18 Aprecia Pharmaceuticals Compny Rapidly dispersible dosage form of topiramate
CN103462917A (en) * 2013-09-12 2013-12-25 南京正宽医药科技有限公司 Antiviral acyclovir tablet and preparation method thereof
EP3468382A4 (en) * 2016-06-14 2020-01-22 Prevtec Microbia Inc Animal feed pellets including a feed additive, method of making and of using same
US10987311B2 (en) 2017-06-16 2021-04-27 Kashiv Specialty Pharmaceuticals, Llc Extended release compositions comprising pyridostigmine
US10588863B2 (en) 2017-06-16 2020-03-17 Kashiv Biosciences, Llc Extended release compositions comprising pyridostigmine
WO2018232413A1 (en) 2017-06-16 2018-12-20 Kashiv Pharma Llc Gastroretentive dosage forms for sustained drug delivery
CN107375287B (en) * 2017-08-22 2019-11-29 安徽省肿瘤医院 A kind of purposes of atropine sulfate in preparation treatment Primary Hepatic cancer drug
CN107441115A (en) * 2017-08-22 2017-12-08 安徽省肿瘤医院 A kind of purposes of Verapamil joint sodium acid carbonate in primary liver cancer medicine is prepared
CN107349195A (en) * 2017-08-22 2017-11-17 安徽省肿瘤医院 A kind of Verapamil is preparing the purposes in treating metastatic hepatic carcinoma medicine
JP7048770B2 (en) 2018-06-18 2022-04-05 アムニール コンプレックス プロダクツ リサーチ エルエルシー Sustained release composition containing pyridostigmine
JP7034343B2 (en) * 2018-06-27 2022-03-11 アムニール コンプレックス プロダクツ リサーチ エルエルシー Self-regulating permeable gastric retention drug delivery system
WO2020230089A1 (en) 2019-05-14 2020-11-19 Clexio Biosciences Ltd. Treatment of nocturnal symptoms and morning akinesia in subjects with parkinson's disease
WO2022195476A1 (en) 2021-03-15 2022-09-22 Clexio Biosciences Ltd. Gastroretentive devices for assessment of intragastric conditions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH675537A5 (en) * 1988-03-25 1990-10-15 Ciba Geigy Ag
US5096714A (en) * 1988-06-28 1992-03-17 Hauser-Kuhrts, Inc. Prolonged release drug tablet formulations
WO1991006281A1 (en) * 1989-10-26 1991-05-16 Nippon Shinyaku Co., Ltd. Gastric preparation
MX9300110A (en) * 1992-01-13 1994-07-29 Gerhard Gergely PHARMACEUTICAL PREPARATION IN THE FORM OF AN EFFERVESCENCE OR DISINTEGRATION TABLET OR OF AN INSTANT-TYPE GRANULATE AND PROCEDURE FOR ITS PREPARATION.
GB9322314D0 (en) * 1993-10-29 1993-12-15 Scherer Ltd R P Foam generating capsules
DE4403943A1 (en) * 1994-02-08 1995-08-10 Hexal Pharma Gmbh Oral preparation of the preparation with diclofenac sodium
GB9418530D0 (en) * 1994-09-14 1994-11-02 Glaxo Group Ltd Medicaments
US5788987A (en) * 1997-01-29 1998-08-04 Poli Industria Chimica Spa Methods for treating early morning pathologies
IT1293764B1 (en) * 1997-07-23 1999-03-10 Chiesi Farma Spa PHARMACEUTICAL COMPOSITIONS IN THE FORM OF EFFERVESCENT TABLETS CONTAINING AN UNSTABLE ACTIVE IN THE PRESENCE OF WATER

Also Published As

Publication number Publication date
AP2002002410A0 (en) 2002-03-31
OA12003A (en) 2006-04-18
WO2001010405A1 (en) 2001-02-15
CA2378468A1 (en) 2001-02-15
AU774957B2 (en) 2004-07-15
SK1832002A3 (en) 2002-08-06
AU5060499A (en) 2001-03-05
WO2001010419A1 (en) 2001-02-15
EP1206249A4 (en) 2004-12-22
EA200200126A1 (en) 2002-10-31
JP2003506400A (en) 2003-02-18
NZ516959A (en) 2003-10-31
TR200200467T2 (en) 2002-08-21
EP1206249A1 (en) 2002-05-22
CZ2002415A3 (en) 2002-08-14
HUP0202497A3 (en) 2004-05-28
CN1376059A (en) 2002-10-23
HK1047226A1 (en) 2003-02-14
AU6309900A (en) 2001-03-05
IL147966A0 (en) 2002-09-12
MXPA02001272A (en) 2002-07-22
HUP0202497A2 (en) 2002-11-28
BR0012981A (en) 2002-06-18
ZA200200926B (en) 2002-11-27
HRP20020108A2 (en) 2003-12-31

Similar Documents

Publication Publication Date Title
HRP20020108A2 (en) Hydrodynamically balancing oral drug delivery system
NZ513700A (en) Oral drug delivery system
HK1072177A1 (en) Drug delivery device
AU7333601A (en) Drug delivery management system
AU2123200A (en) Drug delivery device
AU2002302890A1 (en) Hydrodynamically balancing oral drug delivery system with biphasic release
EP1061987A4 (en) Drug delivery system
AU3520900A (en) Implantable drug delivery system
EP1087753A4 (en) Targeted liposomal drug delivery system
EP0989878A4 (en) Drug delivery system
EP1021137A4 (en) Drug delivery system
GB2352314B (en) Delivery system
GB0011066D0 (en) Delivery system
GB0029843D0 (en) Drug delivery system
GB9930160D0 (en) Drug delivery
GB9914960D0 (en) Delivery system
AU2002210580A1 (en) Drug delivery system
GB9901133D0 (en) Drug delivery system
GB9902509D0 (en) Drug delivery system
GB9905134D0 (en) Medicament delivery system
GB9923273D0 (en) Medicament delivery system
GB9917470D0 (en) Medicament delivery system
GB9800835D0 (en) Drug delivery system
AU4808000A (en) Drug delivery system
GB9904304D0 (en) Drug delivery

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)